Amount Raised
$75 Million
Round Type
Post-IPO Equity
Description
Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that it has entered into a securities purchase agreement with certain existing and new accredited investors to issue and sell an aggregate of 7,293,084 shares of its common stock (“Common Stock”) at a price of $7.30 per share and pre-funded warrants (“Pre-Funded Warrants”) to purchase up to an aggregate of 2,980,889 shares of common stock at a purchase price of $7.2999 per pre-funded warrant, through a private investment in public equity (“PIPE”) financing. The Pre-Funded Warrants will have an exercise price of $0.0001 per share of Common Stock, be immediately exercisable and remain exercisable until exercised in full. The prices of Common Stock and Pre-Funded Warrants do not include any discounts.
Quick answer
Vigil raised $75 Million in a Post-IPO Equity round, dated August 12, 2022. Vigil is based in Sterling, Colorado, United States.
- How much did Vigil raise?
- Vigil raised $75 Million in a Post-IPO Equity round on August 12, 2022.
- What does Vigil do?
- Vigil offers a proprietary technology platform combining software and hardware to provide comprehensive solutions to the expanding seniors’ housing market.
- Where is Vigil based and how big is it?
- Vigil is based in Sterling, Colorado, United States.
- Who are the decision-makers at Vigil?
- Fundz holds 1 contact at Vigil. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Health Care around the same time
Companies in the same sectors as Vigil that raised within 45 days of this round, from Fundz verified event records.
- GoHealth raised $50M (Corporate Round) on September 26, 2022.
- Whitehawk Therapeutics, Inc. raised $72M on September 26, 2022.
- Damona Pharmaceuticals raised $5.5M (Seed) on September 26, 2022.
- Anebulo Pharmaceuticals raised $6.6M (Post-IPO Equity) on September 26, 2022.
- EXICURE, INC. raised $5.4M on September 26, 2022.
- CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
Who to call at Vigil, and when
A new round usually means Vigil is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vigil raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vigil, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vigil. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vigil raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Vigil raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.